Results 1 to 10 of about 79,932 (302)

Monogenic Lupus: A Developing Paradigm of Disease

open access: yesFrontiers in Immunology, 2018
Monogenic lupus is a form of systemic lupus erythematosus (SLE) that occurs in patients with a single gene defect. This rare variant of lupus generally presents with early onset severe disease, especially affecting the kidneys and central nervous system.
Lourdes Ortiz-Fernández, Amr H Sawalha
exaly   +3 more sources

The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles

open access: yesCells, 2021
The rapid progress in the field of stem cell research has laid strong foundations for their use in regenerative medicine applications of injured or diseased tissues.
Margot Jarrige   +14 more
doaj   +1 more source

Evidence That the Etiology of Congenital Hypopituitarism Has a Major Genetic Component but Is Infrequently Monogenic

open access: yesFrontiers in Genetics, 2021
PurposeCongenital hypopituitarism usually occurs sporadically. In most patients, the etiology remains unknown.MethodsWe studied 13 children with sporadic congenital hypopituitarism. Children with non-endocrine, non-familial idiopathic short stature (NFSS)
Youn Hee Jee   +14 more
doaj   +1 more source

Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones

open access: yesStem Cell Research & Therapy, 2023
Background CRISPR/Cas9 editing systems are currently used to generate mutations in a particular gene to mimic a genetic disorder in vitro. Such “disease in a dish” models based on human pluripotent stem cells (hPSCs) offer the opportunity to have access ...
Elie Frank   +9 more
doaj   +1 more source

RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features

open access: yesFrontiers in Immunology, 2022
PurposeReceptor-interacting serine/threonine-protein kinase 1 (RIPK1) is an important regulator of necroptosis and inflammatory responses. We present the clinical features, genetic analysis and immune work-up of two patients with infantile-onset ...
Mutaz Sultan   +30 more
doaj   +1 more source

Estimating the Prevalence of De Novo Monogenic Neurodevelopmental Disorders from Large Cohort Studies

open access: yesBiomedicines, 2022
Rare diseases impact up to 400 million individuals globally. Of the thousands of known rare diseases, many are rare neurodevelopmental disorders (RNDDs) impacting children. RNDDs have proven to be difficult to assess epidemiologically for several reasons.
Madelyn A. Gillentine   +2 more
doaj   +1 more source

The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects

open access: yesFrontiers in Genetics, 2022
Familial hypercholesterolemia (FH) is an inherited disease characterized by reduced efficiency of low-density lipoprotein-cholesterol (LDL-C) removal from the blood and, consequently, an increased risk of life-threatening early cardiovascular ...
Ilhame Diboun   +10 more
doaj   +1 more source

Pain in monogenic Parkinson’s disease: a comprehensive review

open access: yesFrontiers in Neurology, 2023
Pain, a challenging symptom experienced by individuals diagnosed with Parkinson’s disease (PD), still lacks a comprehensive understanding of its underlying pathophysiological mechanisms.
Parisa Alizadeh   +5 more
doaj   +1 more source

Monogenic Diabetes Modeling: In Vitro Pancreatic Differentiation From Human Pluripotent Stem Cells Gains Momentum

open access: yesFrontiers in Endocrinology, 2021
The occurrence of diabetes mellitus is characterized by pancreatic β cell loss and chronic hyperglycemia. While Type 1 and Type 2 diabetes are the most common types, rarer forms involve mutations affecting a single gene.
Juan Ignacio Burgos   +2 more
doaj   +1 more source

Genetic testing for familial hypercholesterolemia—past, present, and future

open access: yesJournal of Lipid Research, 2021
In the early 1980s, the Nobel Prize winning cellular and molecular work of Mike Brown and Joe Goldstein led to the identification of the LDL receptor gene as the first gene where mutations cause the familial hypercholesterolemia (FH) phenotype.
Marta Futema   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy